Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1085 | 967 | 1089 | 1121 | 1632 | 2850 |
Fund Return | 8.46% | -3.31% | 8.93% | 3.88% | 10.3% | 11.04% |
Place in category | 190 | 802 | 448 | 181 | 46 | 59 |
% in Category | 19 | 84 | 45 | 33 | 9 | 16 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Schroder Global Equity Fund I Acc | 1.89B | 7.06 | 11.71 | 13.08 | ||
Schroder Global Equity Fund I Inc | 1.89B | 7.04 | 11.70 | 13.07 | ||
QEP Global Core Equity Fund A Acc | 149.6M | 16.46 | 10.83 | 12.36 | ||
QEP Global Core Equity Fund A Inc | 54.03M | 16.44 | 10.81 | 12.36 | ||
QEP Global Core Equity Fund X Acc | 646.85M | 16.72 | 11.16 | 12.71 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 4.07B | 10.92 | 7.98 | 12.62 | ||
Wellington Global Health Care EquiG | 2.15B | 5.25 | 5.27 | 13.12 | ||
Global Health Care Fund W Acc GBP | 112.79M | 8.57 | 4.09 | 10.65 | ||
Adamant Medtech I GBP | 1.58B | 8.97 | 1.03 | 12.78 | ||
Pharmaceuticals Index Trust F Acc | 263.44K | 8.57 | 5.66 | 10.62 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 7.23 | 745.4 | -0.73% | |
Merck&Co | US58933Y1055 | 6.65 | 101.16 | +2.00% | |
Eli Lilly | US5324571083 | 6.37 | 755.00 | +0.93% | |
Thermo Fisher Scientific | US8835561023 | 4.96 | 514.20 | +0.18% | |
AstraZeneca | GB0009895292 | 3.84 | 10,474.0 | 0.00% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Neutral | Buy |
Technical Indicators | BUY | Strong Sell | BUY |
Summary | Neutral | Sell | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review